Bronze Sponsor

The Clean Biologics group provides comprehensive and integrated services to the biopharmaceutical industry. The group uses its know-how to perform its activities in compliance with Good Manufacturing Practices (GMP), through its three subsidiaries: Clean Cells, Naobios and Biodextris.

· Clean Cells is a pharmaceutical establishment that offers

  • quality control in biological safety and functionality in biopharmaceutical products in a regulatory context in various applications, such as recombinant proteins, therapeutic antibodies, viral vaccines and cell and gene therapy products,
  • production of GMP cell banks and virus seed stock and associated quality control as one stop shop

· Naobios, a pharmaceutical establishment is a CDMO providing bioprocess development and GPM production for clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors.

· Biodextris is a CDMO provides analytical and process development, and clinical batches manufacturing of prokaryotic and eukaryotic system protein vaccines.

The Clean Biologics group, Clean Cells and Naobios are based in Western France. Biodextris is based in Laval (Montreal), Canada. Clean Biologics was established in 2018 with the ArchiMed fund as a stakeholder. The group currently employs more than 200 staff with customers all around the world.


Siège social : 4 rue Nicolas Sadi Carnot

Z.A. du Point du Jour


Tél : +33 (0)2 51 27 57